Q1 2019 Holdings
Filed 2019-05-15 | 24 holdings | $5.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Bausch Health Cos Inc(BHC) | COM | 071734107 | $5.1M | 205,660 | 86.3% |
| BioMarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $733.0K | 8,250 | 12.4% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $9.8K | 250,620 | 0.2% |
| Heron Therapeutics Inc(HRTX) | COM | 427746102 | $9.5K | 388,623 | 0.2% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $8.3K | 284,263 | 0.1% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $6.4K | 334,724 | 0.1% |
| UroGen Pharma Ltd(URGN) | COM | M96088105 | $4.9K | 132,589 | 0.1% |
| Global Blood Therapeutics Inc | COM | 37890U108 | $4.6K | 87,099 | 0.1% |
| Stemline Therapeutics Inc | COM | 85858C107 | $4.2K | 325,526 | 0.1% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $3.8K | 45,329 | 0.1% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $3.1K | 148,695 | 0.1% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $2.8K | 210,257 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $2.5K | 21,270 | 0.0% |
| uniQure NV(QURE) | SHS | N90064101 | $2.3K | 38,800 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $2.2K | 90,356 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $2.1K | 24,040 | 0.0% |
| Acorda Therapeutics Inc | COM | 00484M106 | $2.1K | 154,806 | 0.0% |
| Allergan PLC | SHS | G0177J108 | $2.0K | 13,700 | 0.0% |
| Intercept Pharmaceuticals Inc(ICPTUSD) | COM | 45845P108 | $1.3K | 11,952 | 0.0% |
| Kiniksa Pharmaceuticals Ltd | COM CL A | G5269C101 | $1.2K | 67,692 | 0.0% |
| Chiasma Inc(CHMA) | COM | 16706W102 | $1.1K | 203,948 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $995 | 42,865 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $986 | 6,200 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $432 | 3,452 | 0.0% |